Skin cancer and associated factors in patients from the Peruvian highlands
DOI:
https://doi.org/10.35622/j.ram.2022.03.005Keywords:
skin cancer, prevalence, melanocyte, skin neoplasm, radiationAbstract
The purpose of this article was to study the prevalence of skin cancer and associated factors in patients attending the Pathological Anatomy service of the "Manuel Núñez Butrón" regional hospital in Puno - Peru. The methodology used to determine the prevalence of skin cancer and the associated factors was analytical retrospective and non-probabilistic cross-sectional type, the type of sampling was documentary review and the chi-square as statistical design, for which the results were reviewed. laboratory record books and medical records from 2014 to 2018. The results obtained determined the prevalence of skin cancer per year studied; 2014 (8.94%), 2015 (21.43%), 2016 (19, 64%), 2017 (26.79%) and 2018 (23.21%), noting that in 2017 it presents the highest prevalence corresponding to 15 cases and with the basal cell and squamous cell carcinoma types with (12.5 %) for the same year respectively, the type of cancer identified in the five years was melanoma in one (33.92%) with the exception of the year 2017, the factors associated with the prevalence of cancer being the age group of 63–72 years, with occupation of "agriculturist" followed by other occupations s with 16 cases and male in 30 cases (53.57%). Conclusion: The prevalence of skin cancer was 26.79% in 2017, predominating the melanoma type, associated with the factors age, sex and occupation.
References
Alonzo ME, Calderón C, Rubio H, et al. Cáncer de piel en Yucatán: un estudio epidemiológico de 10 años. Dermatologia Cosmet Medica y Quir. 2015;13(1):7-12.
Sarria-Bardales G, Limache-García A. Cancer control in Peru: A comprehensive approach to a public health issue. Rev Peru Med Exp Salud Publica. 2013;30(1):93-98. doi:10.1590/S1726-46342013000100018 DOI: https://doi.org/10.1590/S1726-46342013000100018
Castañeda P, Eljure J. Cancer de piel un problema actual. Artic Revis. 2016;59(2):6-14. https://www.medigraphic.com/pdfs/facmed/un-2016/un162b.pdf
Pavri SN, Clune J, Ariyan S, Narayan D. Malignant melanoma: Beyond the basics. Plast Reconstr Surg. 2016;138(2):330e-340e. doi:10.1097/PRS.0000000000002367 DOI: https://doi.org/10.1097/PRS.0000000000002367
Ministerio de Salud. Analisis de La Situacion Del Cancer En El Peru, 2013.; 2013. https://www.dge.gob.pe/portal/docs/asis_cancer.pdf
Ministerio de Salud. Prevencion y Control Del Cancer. Minist Salud. Published online 2021:1-303. https://www.minsa.gob.pe/presupuestales/doc2021/ANEXO2_6.pdf
INEN. Instituto Nacional de Enfermedades Neoplásicas.; 2021.
Rigel DS, Carucci JA. 504215_Ftp.Pdf. CA Cancer J Clin. 2000;50(4). DOI: https://doi.org/10.3322/canjclin.50.4.215
Collins L, Quinn A, Stasko T. Skin Cancer and Immunosuppression. Dermatol Clin. 2019;37(1):83-94. doi:10.1016/j.det.2018.07.009 DOI: https://doi.org/10.1016/j.det.2018.07.009
Silva E, Tavares R, Paulitsch F, Zhang L. Use of sunscreen and risk of melanoma and non-melanoma skin cancer: a systematic review and meta-analysis. Eur J Dermatology. 2018;28(2):186-201. doi:10.1684/ejd.2018.3251 DOI: https://doi.org/10.1684/ejd.2018.3251
Batz S, Wahrlich C, Alawi A, Ulrich M, Lademann J. Differentiation of Different Nonmelanoma Skin Cancer Types Using OCT. Skin Pharmacol Physiol. 2018;31(5):238-245. doi:10.1159/000489269 DOI: https://doi.org/10.1159/000489269
Leonardi GC, Falzone L, Salemi R, et al. Cutaneous melanoma: From pathogenesis to therapy (Review). Int J Oncol. 2018;52(4):1071-1080. doi:10.3892/ijo.2018.4287 DOI: https://doi.org/10.3892/ijo.2018.4287
Gordon R. Skin cancer: An overview of epidemiology and risk factors. Semin Oncol Nurs. 2013;29(3):160-169. doi:10.1016/j.soncn.2013.06.002 DOI: https://doi.org/10.1016/j.soncn.2013.06.002
Pulitzer M. Merkel Cell Carcinoma. Surg Pathol Clin. 2017;10(2):399-408. doi:10.1016/j.path.2017.01.013 DOI: https://doi.org/10.1016/j.path.2017.01.013
Marks DH, Arron ST, Mansh M. Skin Cancer and Skin Cancer Risk Factors in Sexual and Gender Minorities. Dermatol Clin. 2020;38(2):209-218. doi:10.1016/j.det.2019.10.005 DOI: https://doi.org/10.1016/j.det.2019.10.005
Published
Issue
Section
License
Copyright (c) 2022 Edgar Tejada, Vicky Gonzales, Sheyla Cervantes, Luz Cusi, Wilson Sucari
This work is licensed under a Creative Commons Attribution 4.0 International License.
